中科微点-全球专利检索

  1. Login
  2. Sign Up
Invention Grant
US09249208B2 Citrulline peptides derived from fibrin and recognized by rheumatoid arthritis specific autoantibodies, and the use thereof 有权
衍生自纤维蛋白并被类风湿性关节炎特异性自身抗体识别的瓜氨酸肽及其用途

  • Patent Title: Citrulline peptides derived from fibrin and recognized by rheumatoid arthritis specific autoantibodies, and the use thereof
  • Patent Title (中): 衍生自纤维蛋白并被类风湿性关节炎特异性自身抗体识别的瓜氨酸肽及其用途
  • Application No.: US13489072
    Application Date: 2012-06-05
  • Publication No.: US09249208B2
    Publication Date: 2016-02-02
  • Inventor: Guy Serre , Mireille Sebbag
  • Applicant: Guy Serre , Mireille Sebbag
  • Applicant Address: FR Marcy-L'etoile
  • Assignee: Biomerieux
  • Current Assignee: Biomerieux
  • Current Assignee Address: FR Marcy-L'etoile
  • Agency: Alston & Bird LLP
  • Priority: FR0411782 20041104; FR0413711 20041222; FR0508422 20050808
  • Main IPC: C07K14/75
  • IPC: C07K14/75
Citrulline peptides derived from fibrin and recognized by rheumatoid arthritis specific autoantibodies, and the use thereof
Abstract:
The invention relates to novel citrulline peptides derived from fibrin α and β chains which are recognizable by specific citrulline antiprotein autoantibodies (AAPC) of a rheumatoid arthritis (PR) and to the use thereof for detecting the presence of said specific PR AAPC in a biological sample.
Abstract(Chinese):

本发明涉及衍生自纤维蛋白α和＆bgr的新型瓜氨酸肽; 可通过类风湿性关节炎（PR）的特定瓜氨酸抗蛋白自身抗体（AAPC）识别的链和其用于检测生物样品中所述特异性PR AAPC的存在的用途。

Public/Granted literature
Information query
Espacenet
Patent Agency Ranking
0/0